Peptide Science: synthesis, purity, and how to read a certificate of analysis

Across Evolve Pep Share, the term research peptide means a synthetic amino-acid chain produced for laboratory use, characterised by identity, purity, and storage documentation rather than by any therapeutic indication. A short synthetic peptide may be a hormone fragment, a signalling molecule fragment, a cosmetic-research candidate, or a tool compound for biological assays — the chemistry is the same. The catalogue also includes longer sequences such as bio peptides in general, the chiral single-resin products labelled as biopep references, and the older bio peptide monikers used by some compound libraries.

What changes between research peptides is the documentation discipline of the supplier, not the underlying science. A research peptide is a research peptide whether it is supplied in a 10 mg vial or a 1 g bulk aliquot; the difference between a usable lot and an unusable one lives almost entirely in the certificate of analysis that accompanies the vial. The peptide science pillar you are reading is the home base for the framework Evolve Pep Share uses to evaluate those certificates, and the deeper pages in this cluster expand each piece of that framework.

Almost every research peptide on the open market is produced by solid-phase peptide synthesis (SPPS): amino acids are added one at a time to a resin, with deprotection, coupling, and washing cycles between each addition. Longer or more difficult sequences may be assembled from purified fragments and ligated; bio peptide products that exceed 50 residues typically use a hybrid approach. After cleavage from the resin and a precipitation step, the crude material is purified by preparative HPLC, exchanged into a salt form, lyophilised, and weighed into vials. The final product is a salt of the peptide: the free peptide fraction in a trifluoroacetate (TFA) salt is typically 70–85% by weight, and the counter-ion accounts for the rest.

Understanding SPPS at this level matters because it explains the standard vocabulary of any certificate of analysis. Crude purity is what the synthesis produced; final purity is what the purification achieved; net peptide content is the fraction of vial mass that is actual peptide (the rest being water, residual salt, and counter-ion). Every parameter on a COA descends from these three numbers; if any one of them is missing, the other two are not interpretable.

HPLC (high-performance liquid chromatography) is the workhorse identity-and-purity method for synthetic peptides. A sample is dissolved, pushed through a column under pressure, and detected by UV absorbance at 214 nm (the peptide-bond wavelength). The result is a chromatogram: peaks along a time axis. The main peak area, expressed as a percentage of the total integrated peak area, is what vendors quote as “peptide purity.” If the chromatogram shows a single dominant peak and a handful of small ones under 0.5%, the lot is usually described as ≥95% or ≥98% pure. If the chromatogram shows a flat baseline with multiple shoulders, the lot is impure regardless of the headline number.

Reading an HPLC trace requires the same caveat on every certificate: the percentage is only as honest as the method and the integration. A certificate that quotes “98% purity” without naming the column, the gradient, the detection wavelength, and the lot number is not a useful certificate. The deeper pages in this cluster — on peptide science review, on where to buy peptides in the market tier discussion, and on the lab-method notes collected here — spell out the minimum documentary set every research peptide lot should carry.

HPLC tells you the purity; mass spectrometry tells you whether the main peak is actually the molecule on the label. In electrospray (ESI) or matrix-assisted (MALDI) workflows, the peptide is ionised and the mass-to-charge of the resulting ions is measured. The dominant mass is then compared to the calculated molecular weight of the target sequence. If the observed mass matches the calculated mass within about 0.5 Da and the isotopic envelope matches the expected distribution, the identity claim is supported.

Modern certificates typically include an LC-MS trace as a single combined figure: the HPLC chromatogram with the mass spectrum of the main peak in the corner. This is convenient, but it also means that a missing LC trace should always raise a flag. On a peptide catalogue such as biopep compound listings, look for the combined LC-MS figure, the lot-linked lot number, the integration parameters for the chromatogram, and the calculated-versus-found mass numbers; these four items together are the minimum complete documentary set.

Net peptide content is the single most misunderstood number on a research-peptide COA. A 10 mg vial of a TFA salt of a 30-residue peptide is not 10 mg of peptide; it is somewhere between 7 and 8.5 mg of peptide with the balance being trifluoroacetate counter-ion and water. The exact fraction depends on the sequence (some residues bind more TFA), the lyophilisation efficiency, and the residual moisture. A COA that reports only the gross vial mass without net content is not giving you enough information to compute the molar amount of peptide actually present.

Salt forms — TFA, acetate, chloride, hydrochloride — also matter for downstream work. TFA is the most common because it is what SPPS leaves behind by default; acetate is the typical alternative for biological assays where TFA may interfere; chloride salts are occasionally used for very hydrophobic sequences. The salt form should always be stated on the certificate; if it is not stated, assume TFA by default and confirm by contacting the supplier. The bio peptide line items in many catalogues will specify the salt form on the listing page; the certificate confirms the salt form on the actual lot.

Synthetic peptides are stable when stored dry at −20°C, and most lots carry a recommended retest interval of 12–24 months under those conditions. Once reconstituted, however, the stability story changes: aqueous solutions of most research peptides are stable for a few days at 4°C, a few weeks at −20°C in single-use aliquots, and considerably shorter at room temperature. The pt 141 reconstitution page in this cluster is a worked example of the reconstitution-and-storage workflow applied to one specific peptide; the principles apply across the catalogue.

The retest date on a certificate is the supplier's statement about how long the lot remains within specification when stored correctly. It is not a guarantee — it is the date by which the lot should be re-tested, not necessarily the date by which it becomes unsafe. A lot stored for six months past its retest date in a properly sealed vial at −20°C will usually pass a fresh HPLC test; a lot stored for six months past its retest date at room temperature in a humid lab will not.

Read a certificate of analysis top to bottom in this order: lot number, product name and sequence, net content, HPLC purity and method, MS identity, salt form, fill mass, storage conditions, retest date. Each of those nine items is either present or missing; a certificate with all nine present is a research-grade document, and a certificate with fewer than five of them is not. Vendors vary widely along this axis, and the where to buy pillar is where Evolve Pep Share records which sourcing tiers fall where on the certificate-quality scale.

The most common certificate failures are: (a) a quoted purity with no method, (b) a chromatogram that does not match the headline number, (c) a stated molecular weight that does not match the expected mass of the sequence, (d) a missing or ambiguous net content, and (e) a missing retest date. None of these failures disqualifies a vendor — they disqualify a specific lot. The protocol is to request a fresh certificate, or to test the lot independently. Independent testing is the topic of the bismuth subsalicylate and can pepto bismol make your stool dark pages in this cluster, which use unrelated compounds to illustrate the principle of a third-party check.

The single largest risk in the research-peptide market is not contamination or mis-labelling at the chemistry level — it is missing documentation. A lot that is 60% pure is not dangerous to research; it is a research reagent with a lower concentration. A lot that is 99% pure on paper but unaccompanied by an HPLC trace, an MS confirmation, or a fill mass measurement is a research reagent with an unknown concentration, which is far worse for downstream work because every experiment that uses it carries unquantified uncertainty.

Secondary risks are: sequence mismatches (the supplier synthesised the wrong peptide), salt-form ambiguity (the TFA fraction is higher or lower than expected), residual solvent (acetonitrile, methanol, or TFA carried over from purification, sometimes at levels that interfere with cell assays), and lot drift (the second batch from the same supplier has a different purity profile). Each of these is detectable with the documentary set listed above, and each of them is invisible without it. The where to buy peptides pillar compares sourcing tiers along exactly these axes.

Everything in the peptide science cluster addresses chemistry, documentation, and lot-evaluation. Pages in this cluster include what are pepitas (a side-trip into peptide naming), the pt 141 reconstitution worked example, the reta dosing chart research-context page, and a set of broader reference notes on bio peptide terminology and the biopep compound-class reference.

What this cluster does not cover is human or veterinary use, dosing, outcomes, or any compound-specific therapeutic effect. The site is laboratory-only. Anything on this site that touches a compound-specific effect is documented at the level of supplier marketing language, not at the level of effect claims, and any health question belongs with a qualified clinician. The full scope statement lives on the disclaimer page.